Sex-Dependent Effects of Intestinal Microbiome Manipulation in a Mouse Model of Alzheimer's Disease

Mechanisms linking intestinal bacteria and neurodegenerative diseases such as Alzheimer's disease (AD) are still unclear. We hypothesized that intestinal dysbiosis might potentiate AD, and manipulating the microbiome to promote intestinal eubiosis and immune homeostasis may improve AD-related brain changes. This study assessed sex differences in the effects of oral probiotic, antibiotics, and synbiotic treatments in the App(NL-G-F) mouse model of AD. The fecal microbiome demonstrated significant correlations between bacterial genera in App(NL-G-F) mice and A beta plaque load, gliosis, and memory performance. Female and not male App(NL-G-F) mice fed probiotic but not synbiotic exhibited a decrease in A beta plaques, microgliosis, brain TNF-alpha, and memory improvement compared to no treatment controls. Although antibiotics treatment did not produce these multiple changes in brain cytokines, memory, or gliosis, it did decrease A beta plaque load and colon cytokines in App(NL-G-F) males. The intestinal cytokine milieu and splenocyte phenotype of female but not male App(NL-G-F) mice indicated a modest proinflammatory innate response following probiotic treatment compared to controls, with an adaptive response following antibiotics treatment in male App(NL-G-F) mice. Overall, these results demonstrate the beneficial effects of probiotic only in App(NL-G-F) females, with minimal benefits of antibiotics or synbiotic feeding in male or female mice.